The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
People with disabilities often face a myriad of challenges when realising their right to health; Markaya Henderson from the European Disability Forum tells us why more must be done to promote disability-inclusive healthcare.
The Keep Antibiotics Working campaign is back to alert the public to the risks of antibiotic resistance, urging people to always take their doctor, pharmacist or nurse’s advice.
A poll commissioned by eye research charity Fight for Sight has found that 4 in 10 Brits either has or knows someone with significant sight loss, and a third of these people have experienced mental health issues.
A new study links a recent rise in infant mortality in England to poverty, which they find is partly linked to the insufficient and inaccessible welfare system.
NHS England has announced it has secured a definitive cystic fibrosis drugs agreement with Vertex Pharmaceuticals, to use all three of their UK-licensed medicines.
Resistance to antibiotics used for treating harmful bacteria related to a variety of stomach conditions has more than doubled in 20 years, new research presented at UEG Week Barcelona 2019 has shown.
Young people with cancer are potentially being robbed of the ability to have children as important information around fertility is not being communicated at the earliest opportunity says the cancer charity, Teenage Cancer Trust.
The news that the UK Government is investing in artificial intelligence is hugely welcome, but to truly reap the benefits, AI must be part of a wider scheme of data utilisation, digital process automation and citizen engagement. Peter Ford, Public Sector Industry Principal, Pegasystems tells us more.
Here, we find out about the role that the National Institute of Environmental Health Sciences, a publicly-funded institute, when it comes to funding obesity research in the U.S. today.
